期刊文献+

两性霉素B脂质体注射剂与市售注射剂家兔体内药代动力学行为的比较 被引量:3

The pharmacokinetic characteristics of amphotericin B liposomes injection compared with market injection in rabbits after intravenous administration
下载PDF
导出
摘要 目的 :比较自制的两性霉素B脂质体注射剂 (amphotericinBliposomes ,LAmB)和市售两性霉素B注射剂(marketamphotericinB ,MAmB)在家兔体内的药代动力学行为。 方法 :分别静脉注射单剂量 (1mg·kg-1)的LAmB和MAmB ,用HPLC法测定血浆中的药物浓度 ,用 3P97程序和Excel处理和分析数据 ,求算有关药代动力学参数。结果 :经 3P97程序拟合 ,家兔静脉注射单剂量LAmB和MAmB后其血药浓度 时间数据分别符合权重为 1/C和 1的三室模型 ;静脉注射LAmB和MAmB后Cmax分别为 (8.4± 2 .1)和 (2 .4± 0 .6 )mg·L-1,AUC分别为 (2 2 .5±6 .8)和 (9.0± 1.9)mg·h·L-1,CL分别为 (0 .0 5 0± 0 .0 2 4)和 (0 .114± 0 .0 2 2 )L·h-1,Vc 分别为 (0 .13± 0 .0 4)和(0 .46± 0 .18)L ,可见LAmB比MAmB注射后具有更高的血药浓度水平和更大的血药浓度 时间曲线下面积 ,以及较低的总体清除率和较小的表观分布容积。结论 :LAmB和MAmB在家兔体内的药代动力学行为有显著的不同 ,这些药代动力学特性的改变 。 To compare the pharmacokinetic characteristics of amphotericin B liposomes injection (LAmB) with market amphotericin B injection (MAmB) in rabbits by intravenous administration. Methods: LAmB and MAmB were intravenously administrated to rabbits at a single dosage of 1 mg·kg -1 . The AmB concentrations in plasma samples were determined by HPLC, and the pharmacokinetic parameters were calculated by means of 3P97, and ANOVA were done by means of the Excel software. Results: The concentration time data of LAmB and MAmB after intravenous administration were best fitted according to three compartment model with a weight of 1/C and 1 respectively . After a single intravenous administration, C max of LAmB and MAmB were 8.4±2.1 and 2.4±0.6 mg·L -1 , AUC were 22.5±6.8 and 9.0±1.9 mg·h·L -1 , CL were 0.050±0.024 and 0.114± 0.022 L·h -1 , V c were 0.13±0.04 and 0.46±0.18 L, respectively. Comparing with MAmB, all rabbits showed high plasma levels, large area under the curve values and low clearance, small apparent volume of distribution of LAmB. Conclusion: There were several striking differences between the pharmacokinetics properties of LAmB and MAmB injection in rabbits. All changes of the pharmacokinetics properties will be advantageous to reduce toxicity and improve therapeutic effect.
出处 《北京大学学报(医学版)》 CAS CSCD 北大核心 2001年第3期243-246,共4页 Journal of Peking University:Health Sciences
关键词 两性霉素B 药代动力学 脂质体 注射剂 抗真菌药 Amphotericin B/pharmacokin Liposomes Injection
  • 相关文献

参考文献3

二级参考文献3

  • 1[1]John WH, Thomas JW. Lipid formulation of amphotericin B: recent progress and future directions [J]. Clinical Infectious Diseases,1996, 22(Suppl2): S133
  • 2[2]Brassinne C,Laduron C,Conne A,et al. High-performance liquid chromatographic determination of amphotericin B in human serum [J]. J Chromatogr,1987, 419:401
  • 3[3]Phillipr RB. Quantitative extraction of amphotericin B from serum and its determination by high-pressure liquid chromatography [J]. Antimicrob Agents Chemother,1984,26(3):314

共引文献4

同被引文献19

  • 1冯敏,潘仕荣,张静夏,王琴梅,吴伟荣,李瑞明.两性霉素B长循环纳米粒的研究[J].中国药学杂志,2005,40(15):1156-1159. 被引量:10
  • 2曹烨,王志强,郭颖,冯奉仪,胡晓桦,熊建萍,唐桂棣,管忠震,张力.国产多西紫杉醇治疗晚期非小细胞肺癌的随机对照临床研究[J].癌症,2006,25(8):999-1002. 被引量:14
  • 3Immordino M L, Brusa P, Arpicco S, et al. Preparation, characterization,cytotoxicity and pharmacokinetics of liposomes containing docetaxel [J]. J Control Release, 2003,91 (3) :417- 429.
  • 4Guo W, Johnson J L, Khan S, et al. Paclitaxel quantification in mouse plasma and tissues containing liposome-entrapped paclitaxel by liquid chromatography-tandem mass spectrometry: applicetion to a pharmacokinetics study [J]. Anal Biochem, 2005,336(2 ) : 213-220.
  • 5Martin N, Catalin J, B lachon MF, et al. Assay of paclitaxel (taxol) in plasma and urine by high performance liquid chromatography[J]. J Chromatogr B Biomed Sci, 1998,709:281- 284.
  • 6Rouini MR, Lotfolahi A, Stewart DJ, et al. A rapid reversed phase high performance liquid chromatographic method for the determination of docetaxel (Taxoterc) in human plasma using a column switching technique[J]. J Pharm Biomed Anal, 1998, 17:1243-1247.
  • 7Davis SS, Washington C. Drug Emulsion. European Patent, 1988 0. 296,845A1
  • 8Lance MR, Washington C, Davis SS. Structure and toxicity of amphotericin B/triglyceride emulsion formulations. J Antimicrob Chemother, 1995,36 : 119
  • 9Hiroshl Fukui, Tomohiro Koike, Takashi Nakagawa, et al. Comparision of LNS - AmB, a novel low - dose formulation of amphoterlcin B with lipid nano - sphere( LNS ), with commerical lipid - based formulations, Int J Pharm ,2003,267( 1 ) : 101
  • 10Muller RH,Schmidt S,Buttle I,et al. Solemuls novel technology for the folxnulation of i. v. emulsions with poorly soluble drugs.Int J Pharm ,2004,269 (2) :293

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部